Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients

<div>(a) The 10 hub genes are enriched in promoting the infiltration of cancer-associated fibroblasts (CAFs) using 4 algorithms in the TIMER database. (b) Validating the differential expression of the 10 hub genes in the GEPIA database.</div>

Journal of Oncology

fig7

Figure 7

Figure 7: Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients 

Figure 7 | Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients 